Previous studies have suggested that inhibition of PDE5, and the consequent increase in cellular cGMP, activates PKG, which in turn mediates the phosphorylation and subsequent proteolysis of β-catenin (an oncogenic protein which is responsible for the transcription of important growth regulatory genes that enhance tumor cell proliferation and survival) [20,21]. This evidence concerns the gene PDE5A and neoplasm.